OPPapers.com

Geneone Benchmarking

Running head: Gene One Benchmarking

Gene One Benchmarking
University of Phoenix

Introduction
Making the decision to transition from a private to public company, Gene One faces many obstacles that must be overcome in order to be established as strong competitor on Wall Street. The goal of Gene One is to go IPO within 3 years and increase annual growth targets by 40 percent without sacrificing the culture of the organization. Having received resignations from top executives based on the company's decision to go public, Gene One has the challenge of forming a senior leadership team that is capable of making the transition. The team needs to ensure requirements of the SEC are met to avoid future consequences. By benchmarking other companies, Gene One will be able to learn from the best practices as well as the mistakes that have been made when going IPO. Taking advantage of this information will lead to a successful transition and allow Gene One to accomplish the goals executives have set forth.
Course Concepts
Formalization and Span of Control are two course concepts that are reflective in Entergy Corporation and Pfizer Pharmaceuticals. "Formalization is the degree to which organizations standardize behavior through rules, procedures, formal training, and related mechanisms. In other words, formalization represents the establishment of standardization as a coordinating mechanism."(McShane and Glinow, 2005).
J. Wayne Leonard, CEO since 1999 has been responsible for leading the organization and setting philosophies and long-term strategies that are consistently applied and implemented. "CEOs and other employees with strong security needs and a low tolerance for ambiguity like working in highly formalized organizations, others become alienated and feel powerless in formalized areas" (McShane and Glinow, 2005). Employees at Pfizer and Entergy Corporation share the need for strong security and low ambiguity.
The Span of Control describes the...